ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,235.48
-0.60%
Dow Jones
38,111.48
-0.86%
US Dollar vs MXN
17.0437
0.20%
Brent Oil
81.96
0.01%
Bitcoin
68,288.06
-0.11%
Registration Strip Icon for monitor Monitoree múltiples cotizaciones en tiempo real de los principales intercambios, como la Bolsa de Valores de Londres, NASDAQ, NYSE, AMEX, Bovespa y más.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Spring Bank Pharmaceuticals Inc (SBPH)

  7. Spring Bank Pharmaceuticals Inc (SBPH) Noticias

SBPH

Spring Bank Pharmaceutic... (SBPH)

Spring Bank Pharmaceuticals Inc
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:SBPH
FechaHoraFuenteTítuloSímboloCompañía
17/03/202315:24Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:SBPHSpring Bank Pharmaceuticals Inc
14/03/202305:05Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:SBPHSpring Bank Pharmaceuticals Inc
09/03/202308:22Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:SBPHSpring Bank Pharmaceuticals Inc
09/03/202307:44Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:SBPHSpring Bank Pharmaceuticals Inc
09/03/202307:38Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:SBPHSpring Bank Pharmaceuticals Inc
09/03/202307:28Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:SBPHSpring Bank Pharmaceuticals Inc
09/03/202307:22Edgar (US Regulatory)Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or Retired Securities Initial Filing Amendments (25-nse)NASDAQ:SBPHSpring Bank Pharmaceuticals Inc
09/03/202307:08Edgar (US Regulatory)Amended Tender Offer Statement by Third Party (sc To-t/a)NASDAQ:SBPHSpring Bank Pharmaceuticals Inc
07/03/202308:19Edgar (US Regulatory)Amended Statement of Ownership: Solicitation (sc 14d9/a)NASDAQ:SBPHSpring Bank Pharmaceuticals Inc
14/02/202315:15Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:SBPHSpring Bank Pharmaceuticals Inc
10/11/202215:37Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:SBPHSpring Bank Pharmaceuticals Inc
09/09/202215:22Edgar (US Regulatory)Amended Quarterly Report (10-q/a)NASDAQ:SBPHSpring Bank Pharmaceuticals Inc
09/09/202215:16Edgar (US Regulatory)Amended Annual Report (10-k/a)NASDAQ:SBPHSpring Bank Pharmaceuticals Inc
07/07/202210:40Edgar (US Regulatory)Statement of Ownership: Solicitation (sc 14d9)NASDAQ:SBPHSpring Bank Pharmaceuticals Inc
07/07/202205:05Edgar (US Regulatory)Tender Offer Statement by Third Party (sc To-t)NASDAQ:SBPHSpring Bank Pharmaceuticals Inc
23/06/202215:59Edgar (US Regulatory)Written Communication by the Subject Company Relating to a Third Party Tender Offer (sc14d9c)NASDAQ:SBPHSpring Bank Pharmaceuticals Inc
23/06/202214:39Edgar (US Regulatory)Written Communication Relating to an Issuer or Third Party (sc To-c)NASDAQ:SBPHSpring Bank Pharmaceuticals Inc
27/04/202215:32Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:SBPHSpring Bank Pharmaceuticals Inc
22/04/202215:06Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:SBPHSpring Bank Pharmaceuticals Inc
15/03/202206:12Edgar (US Regulatory)Annual Report (10-k)NASDAQ:SBPHSpring Bank Pharmaceuticals Inc
01/03/202217:02Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:SBPHSpring Bank Pharmaceuticals Inc
24/08/202117:34Edgar (US Regulatory)Amended Statement of Changes in Beneficial Ownership (4/a)NASDAQ:SBPHSpring Bank Pharmaceuticals Inc
13/08/202108:12Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3)NASDAQ:SBPHSpring Bank Pharmaceuticals Inc
26/05/202115:32Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:SBPHSpring Bank Pharmaceuticals Inc
06/05/202115:58Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:SBPHSpring Bank Pharmaceuticals Inc
03/12/202016:09Edgar (US Regulatory)Statement of Beneficial Ownership (sc 13d)NASDAQ:SBPHSpring Bank Pharmaceuticals Inc
24/11/202017:56Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:SBPHSpring Bank Pharmaceuticals Inc
20/11/202011:59PR Newswire (US)F-star Therapeutics Completes Combination with Spring Bank PharmaceuticalsNASDAQ:SBPHSpring Bank Pharmaceuticals Inc
20/11/202011:53PR Newswire (US)CORRECTING and REPLACING Spring Bank Pharmaceuticals Stockholders Approve Combination with F-star TherapeuticsNASDAQ:SBPHSpring Bank Pharmaceuticals Inc
19/11/202016:00GlobeNewswire Inc.Spring Bank Pharmaceuticals Stockholders Approve Combination with F-star TherapeuticsNASDAQ:SBPHSpring Bank Pharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:SBPH

Su Consulta Reciente

TG
LN00
Cult Food Science
LSE
46HM
Sg Issuer 27
AMEX
CAD
BOV
BRFSG14
BRFSG14 Ex:14
COIN
PHXXXETH
Phoenix Token
TSXV
MNU
USOTC
JKSSY
Jinke Smart Services (PK)
LSE
RFG
Roebuck Food Group Public
LSE
ZA81
Severn T.u 34
LATK
TGRDUSDT
Tigerdogi
LSE
AG08
Sant Uk 28
KRKN
JUNOUSD
JUNO
COIN
BHCCCUST
BHCCCOIN
LSE
FC37
Qnb Fin 25
TG
1RR1
Rokmaster Resources
EU
ALDRV
Drone Volt
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados